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The microcirculation is the part of the circulation where oxy-
gen, nutrients, hormones, and waste products are exchanged
between circulating blood and parenchymal cells. Themicro-
circulation includes not only all the vessels with a diameter
<100 µm but also the interactions between blood compo-
nents (circulating cells, coagulation factors), the vessels lined
by the endothelium, and the glycocalyx.
Over the last decade, especially since the development of
new techniques such as orthogonal polarized spectral (OPS)
and sidestream dark field (SDF) imaging, we have been able
to assess alterations in the microcirculation of critically ill
patients at the bedside [1–4]. From the various studies, it is
clear that all components of the microcirculation are altered
early in critical illness, especially during sepsis. Persistence
of these alterations is associated with increased morbidity
and a poor outcome [2, 4, 5]. Interestingly, these alterations
are not correlated with systemic hemodynamics [6], making
monitoring the microcirculation of particular interest for
titrating potential therapies.
So, should we all be assessing the microcirculation
at the bedside and use it to guide therapy in all critically ill
patients? Unfortunately, we are not yet ready for this step!
Indeed, several questions need to be answered before we
try to modulate the microcirculation with any therapeutic
intervention. In this special issue, several recent studies in
this field are published to try and provide some responses to
these remaining questions.
Before microcirculatory monitoring can become wide-
spread, it needs to be standardized: first, in terms of imaging
the sublingual microcirculation, and second, in terms of
quantifying the alterations observed. N. A. R. Vellinga et
al. suggest the development of a picture database from 36
intensive care units (ICUs) worldwide. These authors called
their network: microSOAP (Microcirculatory Shock Occur-
rence in Acutely ill Patients). The aim of this multicenter,
observational study was to collect 500 images from critically
ill patients and to estimate the prevalence of microcirculatory
alterations in ICU patients, related to conventional clinical
and hemodynamic variables. Moreover, this database could
serve as a source for further investigations.
Despite a roundtable involving experts in the field [7],
scoring of microcirculatory alterations remains controversial
[8, 9] and could limit the expansion of this technique. In-
deed, if different scoring techniques are used in different
studies, it is difficult to compare studies and patients. In this
special issue, M. O. Pozo et al. compared different methods of
calculating the microvascular flow index (MFI). This index is
commonly used to semiquantitatively characterize the veloc-
ity of microcirculatory perfusion as absent, intermittent,
sluggish, or normal [7, 10]. Three approaches are described
to compute the MFI: (1) the average of the predominant flow
in each of the four quadrants (MFI by quadrants), (2) direct
assessment during bedside video acquisition (MFI point
of care), and (3) the mean value of the MFIs determined
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in each individual vessel (MFI vessel by vessel). In this study,
performed by analyzing 100 pictures from septic patients,
the best correlations were between the MFI vessel by vessel
and RBC velocity (r2 : 0.61, P < 0.0001) and between the
MFI vessel by vessel and the fraction of perfused small vessels
(r2 : 0.96, P < 0.0001). Although MFI measurement reflects
the magnitude of microvascular perfusion, the different
approaches are not interchangeable. As noted by the authors,
however, although the MFI vessel by vessel approach may
seem to be preferable, it is time consuming and does not
facilitate use of the technique at the bedside.
Also in this issue, E.–S. Tripodaki et al. and A. P. C. Top
et al. introduce new pieces into the puzzle of the relationship
of the microcirculation and systemic hemodynamics. First,
Tripodaki et al. evaluate the relationship of muscle microcir-
culation to systemic parameters and outcome after cardiac
surgery. The authors studied the microcirculation using
near-infrared spectroscopy (NIRS) and the vascular occlu-
sion technique. They observed good correlations between
NIRS-derived variables and cardiac output, lactate, andmor-
tality. These relationships have been described previously in
septic shock [11] but this is the first time they have been
demonstrated in cardiac surgery patients. The dependence
of the microcirculation on systemic hemodynamics is a
controversial issue. In septic shock, sublingual microvascular
perfusion is independent of either cardiac output or blood
pressure [4]; therefore, the microcirculation may behave as
an independent compartment of the cardiovascular system.
Increasing blood pressure with norepinephrine, however, did
affect the sublingual microcirculation showing that some
dependency is still present [12].
In this context, G. Hernandez et al. investigated the
microcirculation of a particular critically ill septic pop-
ulation: septic patients with arterial hypotension without
elevated lactate concentrations. In an earlier study, these
authors showed that persistent sepsis-induced hypotension
without hyperlactatemia was associated with less severe
organ dysfunction and a very low mortality risk (5.2 versus
17.4% for patients with lactate concentrations >2.5mmol/L)
[13]. In the present study, the authors used an SDF imaging
device to study the microcirculation of 45 of these patients.
There were relatively few abnormalities in this population, as
shown by amedianMFI value of 2.4 and amedian percentage
of perfused vessels of 87.3%. This study tends to support
the notion that patients with persistent sepsis-induced
hypotension without hyperlactatemia exhibit a distinctive
clinical and physiological profile within the spectrum of
septic shock. This subject should be addressed in future
studies.
A. P. C. Top et al. studied the behavior of the sublingual
microcirculation after the start of ECMO therapy in neonates
with severe respiratory failure. ECMO usually induces an
improvement in hemodynamics and an immediate decrease
in vasopressor needs. Nevertheless, beneficial cardiovascular
effects after ECMO were not evident in this study as
shown by unchanged blood pressure and no changes in
infusions of vasoactive or inotropic drugs. Simultaneously,
the sublingual microcirculation failed to improve and the
alterations present at baseline remained present. In contrast,
a group of patients on mechanical ventilation, with similar
derangements at baseline, showed a decrease in microvascu-
lar perfusion over time. These findings suggest that ECMO
could have a delayed effect on the microcirculation and
thus prevent a further deterioration in microvascular flow.
Unfortunately, the lack of cardiac output measurements
precludes a fuller understanding of these results.
Finally, after works on measurements of the microcir-
culation at the bedside, studies on other compounds of the
microcirculation, such as the glycocalyx or red blood cells
(RBCs), are reported. Enzymatic degradation of the glyco-
calyx induces vascular leakage ex vivo, so S. A. Landsverk
et al. investigated enzymatic treatment in an in vivo whole
body hamster model. In addition to looking at the effects of
degradation of the glycocalyx on endothelial leakage, these
authors also investigated the potential effects of this process
on the microcirculation. After injection of hyaluronidase,
they measured plasma volume and functional capillary den-
sity as markers of the microcirculation. Enzyme treatment
did not induce changes in plasma or albumin volumes,
but reduced functional capillary density. There was no
correlation between plasma hyaluronan concentrations and
plasma volume or microcirculatory disturbances, despite a
50–100 fold increase in plasma hyaluronan. To explain their
results, the authors suggest that impaired mechanotransduc-
tion associated with vasoconstriction, mainly due to loss of
hyaluronan from the endothelial glycocalyx, was a possible
mechanism [14]. Another possibility is the increased RBC
rigidity at higher hyaluronan concentrations [15].
In another article, Y. Serroukh et al. comprehensively
review the alterations in the erythrocyte membrane that
occur in sepsis. This issue is potentially important to explain
the microcirculatory abnormalities in sepsis. The authors
discuss the alterations in the components of the RBC
membrane that have previously been described. This mem-
brane is essential for RBC deformability and rheology, and
changes in the membrane and its complex interactions could
significantly affect the microcirculation. Although clinical
evidence is limited, RBC rheologic alterations in sepsis and
their effects on blood flow and oxygen transport may have
important implications, and improved understanding of the
underlying mechanisms is important. Consequently, this
review not only contributes to our understanding of current
knowledge but also provides a framework for future research.
In conclusion, this special issue highlights the distur-
bances in the microcirculation in critically ill patients and
presents some answers to important questions concerning
methodology or particular populations of patients. These
articles provide some additional pieces to the complex puzzle
of optimizing treatment of the critically ill patient!
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